Wall Street analysts expect Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) to announce ($0.20) earnings per share for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates for Verona Pharma PLC American Depositary Share’s earnings, with the lowest EPS estimate coming in at ($0.35) and the highest estimate coming in at ($0.06). The company is scheduled to report its next earnings report on Monday, January 1st.

Zacks’ earnings per share calculations are an average based on a survey of sell-side research analysts that that provide coverage for Verona Pharma PLC American Depositary Share.

Several brokerages recently commented on VRNA. SunTrust Banks, Inc. began coverage on Verona Pharma PLC American Depositary Share in a research report on Monday, May 22nd. They issued a “buy” rating and a $26.00 target price for the company. Stifel Nicolaus began coverage on Verona Pharma PLC American Depositary Share in a research report on Monday, May 22nd. They issued a “buy” rating and a $22.00 target price for the company. Jefferies Group LLC reissued a “buy” rating and set a $26.00 price objective on shares of Verona Pharma PLC American Depositary Share in a report on Monday, May 22nd. Finally, Wedbush began coverage on Verona Pharma PLC American Depositary Share in a report on Monday, May 22nd. They set an “outperform” rating and a $25.00 price objective for the company.

Verona Pharma PLC American Depositary Share (NASDAQ VRNA) remained flat at $12.64 during mid-day trading on Monday. 16 shares of the company’s stock were exchanged. The stock’s market capitalization is $81.15 million. The firm has a 50 day moving average of $13.65 and a 200-day moving average of $13.65. Verona Pharma PLC American Depositary Share has a one year low of $11.05 and a one year high of $17.50.

ILLEGAL ACTIVITY NOTICE: “Zacks: Brokerages Anticipate Verona Pharma PLC American Depositary Share (VRNA) to Announce -$0.20 EPS” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2017/06/19/zacks-brokerages-anticipate-verona-pharma-plc-american-depositary-share-vrna-to-announce-0-20-eps.html.

Get a free copy of the Zacks research report on Verona Pharma PLC American Depositary Share (VRNA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Verona Pharma PLC American Depositary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma PLC American Depositary Share and related companies with MarketBeat.com's FREE daily email newsletter.